Tevogen Bio Holdings Inc.
TVGN
$1.08
$0.088.00%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 7.42M | 2.82M | 4.47M | 8.71M | 1.10M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.36M | 6.09M | 8.60M | 29.52M | 2.01M |
| Operating Income | -9.36M | -6.09M | -8.60M | -29.52M | -2.01M |
| Income Before Tax | -9.44M | -5.88M | -9.66M | 11.26M | -3.63M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9.44M | -5.88M | -9.66M | 11.26M | -3.63M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.44M | -5.88M | -9.66M | 11.26M | -3.63M |
| EBIT | -9.36M | -6.09M | -8.60M | -29.52M | -2.01M |
| EBITDA | -9.32M | -6.05M | -8.56M | -29.48M | -1.97M |
| EPS Basic | -0.09 | -0.03 | -0.04 | 0.08 | -0.15 |
| Normalized Basic EPS | -0.06 | -0.02 | -0.04 | -0.14 | -0.06 |
| EPS Diluted | -0.09 | -0.03 | -0.04 | 0.08 | -0.15 |
| Normalized Diluted EPS | -0.06 | -0.02 | -0.04 | -0.14 | -0.06 |
| Average Basic Shares Outstanding | 106.69M | 170.17M | 154.17M | 137.33M | 24.75M |
| Average Diluted Shares Outstanding | 106.69M | 170.17M | 154.17M | 137.33M | 24.75M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
